KarXT

xanomeline-trospium · Karuna Therapeutics, a Bristol Myers Squibb company

Drug timelines are a Plus or Pro feature.

41 regulatory and trial events tracked for KarXT, covering 2020-09-28 to 2026-06-22. Get the full timeline:

Most recent: Clinical Trial Results: Study to Assess Safety and Effectiveness of Slowly Increasing Dose and Food Effect of KarXT in Participants With Schizophrenia [Phase 3]

See pricing